Exploring the Association Between Lipid-Lowering Medications and Dry Eye Disease in COVID-19 Patients
romanian journal of ophthalmology · 2025
DOI: 10.22336/rjo.2025.82 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift romanian journal of ophthalmology, 2025. Verfasst von Konstantin Yaakov Gushansky und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Dry Eye Syndromes, COVID-19, SARS-CoV-2, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
To explore the associations between systemic lipid-lowering medications and dry eye disease (DED) in patients hospitalized for SARS-CoV-2.
Methods
This retrospective cohort study analyzed electronic medical records of SARS-CoV-2 patients hospitalized at Shaare Zedek Medical Center from April 1, 2020, to December 31, 2024. Adults without a previous DED diagnosis who had an ophthalmologic examination confirming no DED within the year preceding hospitalization were included. Exclusions included ICU admissions, specific systemic conditions, ocular surgeries, and systemic medications known to induce DED. Patients were categorized into those who developed DED within six months post-hospitalization and those who did not.
Results
Among the 1,165 patients, 167 (14.3%) developed DED post-hospitalization. After adjusting for age, gender, and SARS-CoV-2 vaccination status, an inverse association between statins and dry eye disease was evident. Treatment with any statin was associated with reduced odds of developing dry eye disease (OR 0.289, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Shaare Zedek Medical Center, Jerusalem, Israel.
- Helsinki Retina Research Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Keye Eye Center, 326 Teheran-ro, Gangnam-gu, Seoul, South Korea.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
- Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland.
Zitieren
APA
Gushansky, K. Y., Sutinen, P., Jeon, S., & Tuuminen, R. (2025). Exploring the Association Between Lipid-Lowering Medications and Dry Eye Disease in COVID-19 Patients. romanian journal of ophthalmology. https://doi.org/10.22336/rjo.2025.82
Vancouver
Gushansky KY, Sutinen P, Jeon S, Tuuminen R. Exploring the Association Between Lipid-Lowering Medications and Dry Eye Disease in COVID-19 Patients. romanian journal of ophthalmology. 2025. doi:10.22336/rjo.2025.82
BibTeX
@article{Gushansky2025,
author = {Gushansky, Konstantin Yaakov and Sutinen, Pinja and Jeon, Sohee and Tuuminen, Raimo},
title = {Exploring the Association Between Lipid-Lowering Medications and Dry Eye Disease in COVID-19 Patients},
journal = {romanian journal of ophthalmology},
year = {2025},
doi = {10.22336/rjo.2025.82}
}
EUVIMED